How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,009 results for

Spondyloarthropathy

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

261. Coexistence of a Ghon Complex, Pott’s Disease, and Hip Arthritis in a Child (PubMed)

and hip arthritis in a patient who recovered after 12 months of antituberculosis therapy.A 16-year-old girl presented to the outpatient otolaryngology clinic with painless swelling of the neck, and to the physical medicine and rehabilitation clinic with complaints of hip and low back pain that mimicked spondyloarthropathy. She was eventually referred to the outpatient pediatric clinic. Her acute-phase reactants were high, and hilar lymphadenopathy was evident on chest x-ray. On computerized tomography

Full Text available with Trip Pro

2016 Iranian Red Crescent medical journal

262. Recombinant Salmonella typhimurium outer membrane protein A is recognized by synovial fluid CD8 cells and stimulates synovial fluid mononuclear cells to produce interleukin (IL)‐17/IL‐23 in patients with reactive arthritis and undifferentiated spondyl (PubMed)

Recombinant Salmonella typhimurium outer membrane protein A is recognized by synovial fluid CD8 cells and stimulates synovial fluid mononuclear cells to produce interleukin (IL)‐17/IL‐23 in patients with reactive arthritis and undifferentiated spondyl In developing countries, one-third of patients with reactive arthritis (ReA) and undifferentiated spondyloarthropathy (uSpA) are triggered by Salmonella typhimurium. Synovial fluid mononuclear cells (SFMCs) of patients with ReA and uSpA

Full Text available with Trip Pro

2016 Clinical and experimental immunology

263. Cardiac Involvement in Ankylosing Spondylitis (PubMed)

Cardiac Involvement in Ankylosing Spondylitis Ankylosing spondylitis is one of the subgroup of diseases called "seronegative spondyloarthropathy". Frequently, it affects the vertebral colon and sacroiliac joint primarily and affects the peripheral joints less often. This chronic, inflammatory and rheumatic disease can also affect the extraarticular regions of the body. The extraarticular affections can be ophthalmologic, cardiac, pulmonary or neurologic. The cardiac affection can be 2-10

Full Text available with Trip Pro

2016 Journal of clinical medicine research

264. Autoimmune/Inflammatory Arthritis Associated Lymphomas: Who Is at Risk? (PubMed)

Autoimmune/Inflammatory Arthritis Associated Lymphomas: Who Is at Risk? Specific autoimmune and inflammatory rheumatic diseases have been associated with an increased risk of malignant lymphomas. Conditions such as rheumatoid arthritis (RA), primary Sjögren's syndrome (pSS), systemic lupus erythematosus (SLE), dermatomyositis, and celiac disease have been consistently linked to malignant lymphomas. Isolated cases of lymphomas associated with spondyloarthropathies and autoinflammatory diseases

Full Text available with Trip Pro

2016 BioMed research international

265. Pegloticase failure and a possible solution: Immunosuppression to prevent intolerance and inefficacy in patients with gout. (PubMed)

% decrease), resolution of gouty attacks, maintenance of low serum urate (sUA) level, absence of infusion reactions, and good toleration of the treatment by the patient. Two transient increases in sUA (maximal sUA 1.0 and 6.2mg/dL, respectively), were associated with azathioprine non-compliance and resolved with azathioprine reinstitution. Literature review confirmed successful use of DMARDs for prevention of anti-drug antibodies to anti-TNF-α therapies in RA, spondyloarthropathies, and inflammatory

2016 Seminars in arthritis and rheumatism

266. Certain Autoimmune Manifestations Are Associated With Distinctive Karyotypes and Outcomes in Patients With Myelodysplastic Syndrome: A Retrospective Cohort Study. (PubMed)

) was the most prevalent AIM (n = 24 36%]), followed by Behcet disease (10 [15%]), rheumatoid arthritis (9 [13%]), vasculitis (8 [12%]), myositis (3 [4%]), spondyloarthropathy (3 [4%]), and systemic lupus erythematous (2 [3%]). ND and vasculitis occurred at the time of MDS diagnosis, whereas other AIMs occurred years after MDS diagnosis. Deletion of 5q was associated with ND (P = 0.001), whereas trisomy 8 was associated with Behcet disease (P = 0.015). Strikingly, ND was associated with a 1.8-fold increase

Full Text available with Trip Pro

2016 Medicine

267. Non-conventional forms of HLA-B27 are expressed in spondyloarthritis joints and gut tissue. (PubMed)

Non-conventional forms of HLA-B27 are expressed in spondyloarthritis joints and gut tissue. Human leukocyte antigen (HLA)-B27 (B27) is the strongest genetic factor associated with development of Ankylosing Spondylitis and other spondyloarthropathies (SpA), yet the role it plays in disease pathogenesis remains unclear. We investigated the expression of potentially pathogenic non-conventional heavy chain forms (NC) of B27 in synovial and intestinal tissues obtained from SpA patients. We also

Full Text available with Trip Pro

2016 Journal of Autoimmunity

268. Can power Doppler ultrasound of the entheses help in classifying recent axial spondyloarthritis? Data from the DESIR cohort (PubMed)

% European Spondyloarthropathy Study Group criteria and 59% both.In a cohort of patients with recent IBP, the prevalence of PDUS enthesitis was low (14.4%); however, its specificity for classifying patients as axSpA according to ASAS criteria was high (83.5%). PDUS enthesitis might be of additional value for classifying as patients with axSpA IBP who do not fulfil ASAS criteria.

Full Text available with Trip Pro

2018 RMD open

269. Feasibility of cardiovascular disease risk assessments in rheumatology outpatient clinics: experiences from the nationwide NOCAR project (PubMed)

referred to their primary care physician for initiation of CVD preventive measures.Data collection (autumn 2015) showed that five of the NOCAR centres had implemented CVD risk assessments. There were 8789 patients eligible for CVD risk evaluation (rheumatoid arthritis (RA), 4483; ankylosing spondylitis (AS), 1663; psoriatic arthritis (PsA), 1928; unspecified and other forms of spondyloarthropathies (SpA), 715) of whom 41.4 % received a CVD risk assessment (RA, 44.7%; AS, 43.4%; PsA, 36.3%; SpA, 30.6

Full Text available with Trip Pro

2018 RMD open

270. Cross-sectional survey of the undergraduate rheumatology curriculum in European medical schools: a EULAR School of Rheumatology initiative (PubMed)

. Similarly, interpretation of investigations undertaken on synovial fluid was taught in only 16 schools. While disease-modifying anti-rheumatic drugs and biological agents, and urate-lowering treatment were included in the curricula of 20 and 21 institutions, respectively, only curricula from 18 schools included core non-pharmacological interventions. Osteoarthritis, gout, rheumatoid arthritis, spondyloarthropathy, polymyalgia rheumatica and lupus were included in the curriculum of all institutions

Full Text available with Trip Pro

2018 RMD open

271. Diagnosis and management of psoriasis and psoriatic arthritis in adults

in the assessment of patients with psoriatic spondyloarthropathy. The BASDAI (Bath Ankylosing Spondylitis Disease Activity Index) consists of 10 cm visual analogue scales used to answer questions pertaining to the five major symptoms of AS: fatigue, spinal pain, joint pain and swelling, areas of localised tenderness and morning stiffness (see Annex 7). 79 The BASFI (Bath Ankylosing Spondylitis Functional Index) measures functional abilities in 10 activities of daily living on a 10 cm visual analogue scale (see

2010 SIGN

273. Sciatica (lumbar radiculopathy)

Improvement [ ] and Guideline for the evidence-informed primary care management of low back pain, published by a Canadian guideline group [ ]. [ ; ; ; ; ; ; ; ; ] Differential diagnosis What else might it be? If there are no suggesting a serious underlying cause, consider the following conditions that may present similarly to sciatica: Referred pain from hip osteoarthritis. For more information, see the CKS topic on . Sacroiliitis in ankylosing spondylitis and other spondyloarthropathies. For more

2015 NICE Clinical Knowledge Summaries

274. Uveitis

is not known; when a cause is identified, it usually includes one of the following [ ; ; ]: Systemic autoimmune disorders, such as: Seronegative spondyloarthropathies (ankylosing spondylitis, juvenile rheumatoid arthritis, Reiter's syndrome, and inflammatory bowel disease). Behçet's disease. Sarcoidosis. Psoriasis (with or without associated arthritis). Multiple sclerosis. Infection. Common infectious causes are herpes simplex, varicella zoster virus, cytomegalovirus, and toxoplasmosis. Less common

2014 NICE Clinical Knowledge Summaries

275. Urinary tract infection (lower) - women

information, see the CKS topics on and . Spondyloarthropathies such as reactive arthritis or Bechet’s syndrome. Malignancy. Gynaecological malignancy (for example ovarian cancer) may present with persistent or frequent increased urinary urgency and/or frequency. Urological malignancy may present with haematuria (visible or non-visible). For further information, see the CKS topic on and . Other infections such as sexually transmitted infections (for example chlamydia, gonorrhoea, genital herpes simplex

2014 NICE Clinical Knowledge Summaries

276. Thoracic Aortic Disease: Guidelines For the Diagnosis and Management of Patients With

Aortic Valve and Associated Congenital Variants in Adults .e52 6.2. Aberrant Right Subclavian Artery .e53 6.3. Coarctation of the Aorta .e53 6.4. Right Aortic Arch .e53 7. In?ammatory Diseases Associated With Thoracic Aortic Disease .e53 7.1. Recommendations for Takayasu Arteritis and Giant Cell Arteritis .e53 7.2. Takayasu Arteritis .e54 7.3. Giant Cell Arteritis .e56 7.4. Behc ¸et Disease .e57 7.5. Ankylosing Spondylitis (Spondyloarthropathies) .e57 7.6. Infective Thoracic Aortic Aneurysms .e57 8

2010 American College of Cardiology

277. A Long-Term Efficacy and Safety Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis

after stopping treatment Have been treated with 1 or more conventional disease-modifying antirheumatic drugs (cDMARDs) Exclusion Criteria: Current or prior use of biologic agents for treatment of Ps or PsA Inadequate response to greater than or equal to 4 conventional disease-modifying antirheumatic drugs (DMARDS) Current use of more than one cDMARDs Diagnosis of active inflammatory arthritic syndromes or spondyloarthropathies other than PsA Have received treatment with interleukin (IL) -17 or IL12

2015 Clinical Trials

278. Study to Compare the Efficacy of Tocilizumab With or Without Glucocorticoid Discontinuation in Rheumatoid Arthritis Participants

the discretion of the investigator Diagnosed with juvenile idiopathic arthritis or juvenile RA and/or RA before the age of 16 years Prior or current inflammatory joint disease other than RA (for example, gout, Lyme disease, sero-negative spondyloarthropathy, including reactive arthritis, psoriatic arthritis, arthropathy of inflammatory bowel disease), or prior or current joint infections Previous history of primary or secondary adrenal insufficiency Previous or Concomitant Prohibited Therapy Treatment

2015 Clinical Trials

279. Anakinra vs. Steroids for the Treatment of Gout Attacks in Patients With Renal Disease (ASGARD): A Feasibility Study

such as systemic lupus erythematosus, mixed connective tissue disease, scleroderma, polymyositis, or significant systemic involvement secondary to rheumatoid arthritis. Con-current immunosuppression/immunomodulatory treatment (Calcineurin inhibitor, anti-proliferative or biologic) therapy for other reason i.e. organ transplant. Prior history or current inflammatory joint disease other than gout (e.g. rheumatoid arthritis (RA), reactive arthritis, psoriatic arthritis, seronegative spondyloarthropathy, Lyme

2015 Clinical Trials

280. Kinesio Taping Efficacy in Chronic Low Back Pain Treatment (KITALO)

structures, spondyloarthropathy, spondylodiscitis). Prior spine surgery. Mental retardation, severe mental illness, substance abuse or dependency, illiteracy. Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor. Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02604290 Locations Layout table for location

2015 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>